Leaders in mycobacteria research are renewing efforts to bring the next generation of researchers to the table to make new discoveries and win the long game against tuberculosis and related diseases.
Researchers at CSU are among the foremost experts on Mycobacterium tuberculosis, the causative agent of the disease, and have for many years been dedicated to understanding its underlying immunopathology.
An international team that includes researchers John Spencer, Ph.D., and Charlotte Avanzi, Ph.D., of the Colorado State University Mycobacteria Research Laboratories has identified leprosy in wild chimpanzees in the West African countries of Guinea-Bissau and Ivory Coast.
A research team at Colorado State University has discovered that drugs used to treat malaria are also effective at treating a pulmonary disease similar to tuberculosis.
Researchers hope this new method will accelerate the development of shorter treatment regimens.
For International Women’s Day, SOURCE sat down with Marcela Henao-Tamayo — an assistant professor in the Department of Microbiology, Immunology and Pathology and director of the Flow Cytometry Core at CSU.
Chimps in both West African sites suffer from leprosy, a disease never before documented in wild chimpanzees.
"What drives me is that we are working towards equal opportunities to live a healthy life. I am completely convinced that the work we are doing can improve health. I wake up thinking there is something important that I can do today, big or small." -Dr. Marcela Henao-Tamayo
Volunteers in the Department of Microbiology, Immunology, and Pathology sewed over 1,000 face masks for employees to wear at work during the COVID-19 pandemic.
The team is selecting pieces of proteins from the virus that are known to elicit an immune response against COVID-19.